Article
Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia.
Cancer science - 1 May 2008
Kiyotani Kazuma, Mushiroda Taisei, Kubo Michiaki, Zembutsu Hitoshi, Sugiyama Yuichi, Nakamura Yusuke
Abstract excerpt
Despite long-term clinical experience with docetaxel, unpredictable severe adverse reactions remain an important determinant for limiting the use of the drug. To identify a genetic factor(s) determining the risk of docetaxel-induced leukopenia/neutropenia, we selected subjects who received docetaxel chemotherapy from samples recruited at BioBank Japan, and conducted a case-control association study. We genotyped...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
